Literature DB >> 31090103

Screening candidate microRNA-mRNA network for predicting the response to chemoresistance in osteosarcoma by bioinformatics analysis.

Penggao Dai1, Yancheng He1, Guosong Luo2, Jiaqi Deng3, Nan Jiang1, Tingting Fang1, Yujuan Li2, Ying Cheng1.   

Abstract

The search for biomarkers is important for providing more targeted treatments for osteosarcoma patients with chemoresistance. In this study, differentially expressed microRNAs (miRNAs) were identified from miRNA expression profiles. And the target messenger RNAs (mRNAs) of miRNA were obtained from two websites in public domains. Analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway by these miRNA targets suggests that they may have potential links to osteosarcoma chemoresistance. In the protein-protein interaction (PPI) network, we screened three subnetworks and 10 hub RNAs, and analyzed through KEGG pathway and searched the PubMed database, indicating that they were significantly associated with drug resistance. Then we found 12 key mRNAs by analyzing the mRNA expression profile. Survival analyses showed that most of the 10 hub mRNAs and 12 key mRNAs had a significant influence on the prognosis of patients with chemoresistance osteosarcoma. A miRNA-mRNA network is constructed by integrating mRNAs and miRNAs information. The network biomarkers in this study have an advantage over traditional single-molecule biomarkers in terms of predictive power. And the mRNAs in this network biomarkers are supported by survival analysis or by existing theories. These results will contribute to the choice of chemotherapy before treatment and the prediction of patient prognosis.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  bioinformatics analysis; biomarkers; chemoresistance; microRNA-mRNA network; osteosarcoma

Year:  2019        PMID: 31090103     DOI: 10.1002/jcb.28938

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

1.  High mobility group box 2 modulates the progression of osteosarcoma and is related with poor prognosis.

Authors:  Shicong Yang; Ziyin Ye; Zhuo Wang; Liantang Wang
Journal:  Ann Transl Med       Date:  2020-09

2.  Co-expression network analysis identifies a gene signature as a predictive biomarker for energy metabolism in osteosarcoma.

Authors:  Naiqiang Zhu; Jingyi Hou; Guiyun Ma; Shuai Guo; Chengliang Zhao; Bin Chen
Journal:  Cancer Cell Int       Date:  2020-06-22       Impact factor: 5.722

3.  Comprehensive analysis of transcriptome data for identifying biomarkers and therapeutic targets in head and neck squamous cell carcinoma.

Authors:  Yu Jin; Xing Qin
Journal:  Ann Transl Med       Date:  2020-03

4.  MicroRNA-26b-5p suppresses the proliferation of tongue squamous cell carcinoma via targeting proline rich 11 (PRR11).

Authors:  Liang Yi; Ying Liu; Anji Xu; Sha Li; Hailin Zhang; Mingjing Peng; Zan Li; Huayi Ren; Jie Dai; Chenhui Luo; Yazhou Xiao; Xiao Zhou; Ying Long
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Association of CASC18/miR-20a-3p/TGFB2 ceRNA axis with occult lymph node metastasis in tongue squamous cell carcinoma.

Authors:  Bo Zhou; Yue Zhou; Ying Liu; Hailin Zhang; Huangxing Mao; Mingjing Peng; Anji Xu; Zan Li; Hui Wang; Haolei Tan; Huayi Ren; Xiao Zhou; Ying Long
Journal:  Mol Med       Date:  2021-08-06       Impact factor: 6.354

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.